Marfan Ailment
Academic International Journal of Medical Update · 2024
DOI: 10.59675/u225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic International Journal of Medical Update, 2024. Verfasst von Ola Abdulwahhab Muslim und 3 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Marfan syndrome is a connective tissue abnormality that leads to various system diseases, such as enlargement of the long bones and problems with the skin, heart, and eyes [1]. The condition is either caused by a novel mutation or an inherited mutation of the fibrillin-1 gene (FBN1). Both mutations are phenotypically identical [2]. The heritable variant is inherited by an autosomal dominant pattern, which means that the disease can be caused by a single copy of the defective gene [3,4]. People who don't have a positive family history of the condition can nonetheless get the disease from de novo mutations. 25% of Marfan syndrome cases are believed to be caused by a novel mutation in the FBN1 gene, although these cases are less common than those with inherited mutations [5,6]. The prevalence of Marfan syndrome varies from 1 in 5000 to 1 in 10,000; there is no discernible racial, ethnic, or gender preference [7].
Zitieren
APA
Muslim, O. A., Bakr, H. M., Jwaziri, A. K., & Ali, K. M. R. (2024). Marfan Ailment. Academic International Journal of Medical Update. https://doi.org/10.59675/u225
Vancouver
Muslim OA, Bakr HM, Jwaziri AK, Ali KMR. Marfan Ailment. Academic International Journal of Medical Update. 2024. doi:10.59675/u225
BibTeX
@article{Muslim2024,
author = {Muslim, Ola Abdulwahhab and Bakr, Hayder Mohammed and Jwaziri, Abdulhussain Kadhim and Ali, Kawther Mohammed Radah},
title = {Marfan Ailment},
journal = {Academic International Journal of Medical Update},
year = {2024},
doi = {10.59675/u225}
}
EUVIMED